Preoperative neutrophil-to-lymphocyte ratio is an independent prognostic marker in patients with laryngeal squamous cell carcinoma
- PMID: 26482899
- PMCID: PMC4615885
- DOI: 10.1186/s12885-015-1727-6
Preoperative neutrophil-to-lymphocyte ratio is an independent prognostic marker in patients with laryngeal squamous cell carcinoma
Abstract
Background: Neutrophil-lymphocyte ratio (NLR) has been shown to be associated with prognosis in various solid tumors. This study aimed to evaluate the prognostic role of NLR in patients with laryngeal squamous cell carcinoma (LSCC).
Methods: A total of 141 LSCC patients were retrospectively reviewed. Patients' demographics were analyzed along with clinical and pathologic data. The optimal cutoff value of NLR was determined using receiver operating characteristic (ROC) curve analysis. The impact of the NLR and other potential prognostic factors on disease-free survival (DFS) and overall survival (OS) was assessed using the Kaplan-Meier method and multivariate Cox regression analysis.
Results: The optimal cutoff value of the NLR was 2.17. In the NLR ≤ 2.17 group, the 1-, 3-, and 5-year DFS rates were 88.2, 73.9 and 69.1 %, respectively, while in the NLR > 2.17 group, the DFS rates were 83.0, 54.6 and 49.2 %, respectively. Correspondingly, the 1-, 3-, and 5-year OS rates were 98.9, 85.1 and 77.4 % in the NLR ≤ 2.17 group and 97.9, 63.8 and 53.3 % in the NLR > 2.17 group, respectively. The multivariate Cox proportional hazard model analysis showed that NLR > 2.17 was a prognostic factor for both DFS [hazard ratio (HR) = 1.869; 95 % confidence interval (CI) 1.078-3.243; P = 0.026] and OS (HR =2.177; 95 % CI 1.208-3.924; P = 0.010).
Conclusion: Our results showed that elevated preoperative NLR was an independent predictor of poor prognosis for patients with LSCC after surgical resection.
Figures



Similar articles
-
Survival and prognostic analysis of preoperative inflammatory markers in patients undergoing surgical resection for laryngeal squamous cell carcinoma.BMC Cancer. 2018 Aug 13;18(1):816. doi: 10.1186/s12885-018-4730-x. BMC Cancer. 2018. PMID: 30103707 Free PMC article.
-
Prognostic value of the neutrophil-to-lymphocyte ratio for overall and disease-free survival in patients with surgically treated esophageal squamous cell carcinoma.Tumour Biol. 2016 Jun;37(6):7149-54. doi: 10.1007/s13277-015-4596-3. Epub 2015 Dec 12. Tumour Biol. 2016. PMID: 26662960
-
A Retrospective Study of The Prognostic Significance of Preoperative Plasma Fibrinogen, Mean Platelet Volume, and the Neutrophil-to-Lymphocyte Ratio in Patients with Laryngeal Squamous Cell Carcinoma.Med Sci Monit. 2019 Jun 18;25:4527-4534. doi: 10.12659/MSM.914426. Med Sci Monit. 2019. PMID: 31210172 Free PMC article.
-
Prognostic role of elevated preoperative systemic inflammatory markers in localized soft tissue sarcoma.Cancer Biomark. 2016;16(3):333-42. doi: 10.3233/CBM-160571. Cancer Biomark. 2016. PMID: 26835589 Review.
-
Prognostic significance of pretreatment neutrophil-to-lymphocyte ratio in melanoma patients: A meta-analysis.Clin Chim Acta. 2018 Sep;484:136-140. doi: 10.1016/j.cca.2018.05.055. Epub 2018 May 29. Clin Chim Acta. 2018. PMID: 29856976 Review.
Cited by
-
Prognostic value of the C-reactive protein/albumin ratio in patients with laryngeal squamous cell carcinoma.Onco Targets Ther. 2017 Feb 15;10:879-884. doi: 10.2147/OTT.S128391. eCollection 2017. Onco Targets Ther. 2017. PMID: 28243123 Free PMC article.
-
Prognostic value of pre-operative peripheral inflammation markers in patients with squamous cell carcinoma of the external auditory canal.Braz J Otorhinolaryngol. 2022 Mar-Apr;88(2):161-167. doi: 10.1016/j.bjorl.2020.05.018. Epub 2020 Jun 24. Braz J Otorhinolaryngol. 2022. PMID: 32624372 Free PMC article.
-
Neutrophil-to-lymphocyte ratio as a prognostic factor for pharyngocutaneous fistula after total laryngectomy.Acta Otorhinolaryngol Ital. 2018 Feb;38(1):31-37. doi: 10.14639/0392-100X-1572. Acta Otorhinolaryngol Ital. 2018. PMID: 29756613 Free PMC article.
-
Role and research progress of hematological markers in laryngeal squamous cell carcinoma.Diagn Pathol. 2023 Apr 20;18(1):50. doi: 10.1186/s13000-023-01335-7. Diagn Pathol. 2023. PMID: 37081512 Free PMC article. Review.
-
Survival and prognostic analysis of preoperative inflammatory markers in patients undergoing surgical resection for laryngeal squamous cell carcinoma.BMC Cancer. 2018 Aug 13;18(1):816. doi: 10.1186/s12885-018-4730-x. BMC Cancer. 2018. PMID: 30103707 Free PMC article.
References
-
- Ghaffar S, Akhtar S, Ikram M, Imam SZ, Sepah YJ. Comparison of different treatment modalities in advanced laryngeal hypopharyngeal squamous cell carcinoma. J Coll Physicians Surg Pak. 2010;20(3):171–4. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources